YOU CAN HELP RESEARCHERS BETTER UNDERSTAND WHO IS AT RISK FOR HEREDITARY CANCER

Welcome to the Prospective Registry Of MultiPlex Testing (PROMPT). This online research registry for patients and their families helps researchers answer the question: “How do genetic variants affect your cancer risk?”

If you’re here, you’ve likely undergone multiplex gene panel testing and were found to have a genetic variant that may be linked to an increased risk of cancer.

Through your participation, you can help researchers collect data to better understand and prevent cancer.

Enrollment link: Click Here

Contact information: prompt@uphs.upenn.edu

View our 2021 newsletter: Click Here

About PROMPT

PROMPT is an online research registry for people who have multiplex gene panels—a newer form of genetic testing that looks for mutations in several different genes at once. All genes on the panels have been linked to an increased risk of cancer, but some risks are better known than others.

Our objective is to follow people with mutations or variants in genes on these panels, so that patients, physicians, and researchers can more clearly understand these lesser-known risks.

About YOU

Using the PROMPT registry, you’ll provide critical information that helps promote scientific discoveries and deeper understanding of cancer susceptibility genes. By engaging in the PROMPT community, you’ll learn more about how mutations in these genes may affect your health and cancer risks.

You’ll provide information about your personal and family health histories as well as contact information. By providing your contact information, you can receive updates from physicians and researchers regarding your genetic information, other research studies, or to obtain more information.

Collaboration

• We have recently forged a relationship with GenomeConnect. GenomeConnect is an online registry, like PROMPT, where individuals can securely share their genetic results and health history.Most notably, GenomeConnect also gives participants the option to connect with others with similar genetic test results, learn about additional research opportunities and receive updates about their genetic test results. To learn more, view their recently recorded webinar that provides and overview of GenomeConnect: Webinar: GenomeConnect Overview July 2025.  

• GenomeConnect will also be hosting a webinar on September 25^th at 12pm ET reviewing the variant classification and reclassification process. If interested, please register here: https://forms.gle/YryzDbEBru4AH8Z4A.